Thus, the CCL28-CCR10 axis may have significant pro-tumor activities in the hypoxic tumor microenvironment by inducing angiogenesis via VEGF and attracting CCR10-expressing Treg cells. The gene discussed is CCR10; the disease is neoplasm.